8102
-
Therapeutics and Clinical Risk Management
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Therapeutics and Clinical Risk Management
(2,215,708) Views
Editor in Chief Professor Garry Walsh
1178-203X
Case reportConcurrent Chagas’ disease and borderline disseminated cutaneous leishmaniasis: The role of amiodarone as an antitrypanosomatidae drug
Alberto E Paniz-Mondolfi, Alexandra M Pérez-Álvarez, Oscar Reyes-Jaimes, Gustavo Socorro, Olga Zerpa, et al
Therapeutics and Clinical Risk Management 2008, 4:659-663
30 June 2008
Case report
The use of fondaparinux for the treatment of venous thromboembolism in a patient with heparin-induced thombocytopenia and thrombosis caused by heparin flushes
Alex C Spyropoulos, Sharyl Magnuson, Sei Keng Koh
Therapeutics and Clinical Risk Management 2008, 4:653-657
30 June 2008
Case report
An “acquired” hemoglobin J variant in a sickle cell disease patient
Nawwar Swedan, Kathleen Nicol, Phylis Moder, Samir Kahwash
Therapeutics and Clinical Risk Management 2008, 4:649-652
30 June 2008
Case report
Valproate-associated reversible encephalopathy in a 3-year-old girl with Pallister-Killian syndrome
Thorsten Gerstner, Nellie Bell, Stephan A Koenig
Therapeutics and Clinical Risk Management 2008, 4:645-647
30 June 2008
Case report
Efficacy of deoxyspergualine for antibody-mediated rejection and proteinuria after kidney transplantation
Hideki Ishida, Kazunari Tanabe
Therapeutics and Clinical Risk Management 2008, 4:641-644
30 June 2008
Original Research
Impact upon clinical outcomes of translation of PNA FISH-generated laboratory data from the clinical microbiology bench to bedside in real time
Tam Ly, Jyoti Gulia, Vasilios Pyrgos, Masashi Waga, Shmuel Shoham
Therapeutics and Clinical Risk Management 2008, 4:637-640
30 June 2008
Original Research
Performance of the OptiMAL® dipstick in the diagnosis of malaria infection in pregnancy
Harry Tagbor, Jane Bruce, Edmund Browne, Brian Greenwood, Daniel Chandramohan
Therapeutics and Clinical Risk Management 2008, 4:631-636
30 June 2008
Original Research
Multiple sclerosis presented as clinically isolated syndrome: the need for early diagnosis and treatment
Sigliti-Henrietta Pelidou, Sotirios Giannopoulos, Sotiria Tzavidi, Georgios Lagos, Athanassios P Kyritsis
Therapeutics and Clinical Risk Management 2008, 4:627-630
30 June 2008
Review
Treatment strategies in mucous membrane pemphigoid
Ann G Neff, Matthew Turner, Diya F Mutasim
Therapeutics and Clinical Risk Management 2008, 4:617-626
30 June 2008
Review
The therapeutic effects of Rho-ROCK inhibitors on CNS disorders
Takekazu Kubo, Atsushi Yamaguchi, Nobuyoshi Iwata, Toshihide Yamashita
Therapeutics and Clinical Risk Management 2008, 4:605-615
30 June 2008
Review
Antiviral treatment in patients with hepatitis C virus-related cirrhosis awaiting liver transplantation
Pierluigi Toniutto, Carlo Fabris, Davide Bitetto, Ezio Fornasiere, Elisa Fumolo, et al
Therapeutics and Clinical Risk Management 2008, 4:599-603
30 June 2008
Review
AAS, growth hormone, and insulin abuse: psychological and neuroendocrine effects
Michael R Graham, Peter Evans, Bruce Davies, Julien S Baker
Therapeutics and Clinical Risk Management 2008, 4:587-597
30 June 2008
Review
Pemetrexed as second-line therapy for advanced non-small-cell lung cancer (NSCLC)
Enriqueta Felip, Rafael Rosell
Therapeutics and Clinical Risk Management 2008, 4:579-585
30 June 2008
Review
Atripla™ – HIV therapy in one pill
Boris Julg, Johannes R Bogner
Therapeutics and Clinical Risk Management 2008, 4:573-577
30 June 2008
Editorial ||FREE PAPER||
Garry M Walsh
Therapeutics and Clinical Risk Management 2008, 4:0-0
01 January 1970
- Have an opinion about one of our articles?
We encourage you to write a Letter to the Editor
- American Acne and Rosacea Society
The American Acne and Rosacea Society (AARS), is a 501(c)(6) non-profit organization dedicated to elevating the understanding and treatment of acne and rosacea.
